IHU Méditerranée Infection
IHU Méditerranée Infection is a French university-hospital institute in Marseille that delivers integrated infectious disease clinical care, advanced diagnostics, and research through ten technology platforms, four research units, and three National Reference Centers, serving French public health authorities and international partners.
- Company typePrivate
- Founded-
- HeadquartersMarseille-en-beauvaisis, France
- Headcount101–250
- GTM typeB2B and B2C
- OfferingServices
What IHU Méditerranée Infection does
IHU Méditerranée Infection is a French university-hospital institute (Institut Hospitalo-Universitaire) headquartered at 19-21 Boulevard Jean Moulin, 13005 Marseille, operating as the Fondation Méditerranée Infection under French foundation law (SIRET 50198088200028). It integrates infectious and tropical disease clinical care, advanced diagnostics, basic and applied research, and higher education within a single purpose-built facility. It serves three primary constituencies: patients requiring specialist infectious and tropical disease care, French public health authorities through three designated National Reference Centers (Rickettsioses, ArboVIRUS, Malaria), and an international research community with formal partnerships spanning Senegal, Vietnam, Cameroon, and Algeria through the Infectiopole Sud network. Pierre-Edouard Fournier serves as the foundation's legal representative.
The institute operates ten specialized technology platforms: next-generation sequencing (NGS), proteomics via MALDI-TOF, culturomics, scanning and transmission electron microscopy, a BSL-3 containment laboratory, biobank, microbial strain collection, insectarium, and veterinary research center. Four research units (MEPHI, RITMES, SESSTIM, UVE) and a portfolio of proprietary bioinformatics databases (URMS, ARG-ANNOT, Beta-lactamase Database, NRPPUR, BUR, OXYTOL, SVARAP/aSVARAP, MG-Digger) underpin core capabilities. Service lines include hospitalization, outpatient consultations, travel medicine and vaccination, diagnostic laboratory testing, epidemiological surveillance, and academic programs spanning Master's through Post-Doctorate, plus 890+ educational videos on YouTube.
The business model is fundamentally public-sector and grant-funded. Clinical services are reimbursed through the French Sécurité Sociale via AP-HM and CHU Timone; research and platform investments are financed through the France 2030 program, ANR competitive grants, the Investir L'Avenir initiative, and Aix-Marseille Université. Commercial activity is nascent and emerging: startup incubation services launched in 2025, the EMERGENCES international congress scheduled for 2027, and the HITACHI educational partnership extend the institute's reach beyond its traditional public funding base. Revenue figures are not publicly disclosed.
IHU Méditerranée Infection firmographics
Firmographics- Name
- IHU Méditerranée Infection
- Legal name
- Fondation Méditerranée Infection
- Website
- https://mediterranee-infection.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- IHU Méditerranée Infection is a French university-hospital institute in Marseille that delivers integrated infectious disease clinical care, advanced diagnostics, and research through ten technology platforms, four research units, and three National Reference Centers, serving French public health authorities and international partners.
- Ownership category
- akta.pro rank
IHU Méditerranée Infection industry classification
Industry- Product category
- Infectious Disease Research and Clinical Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Offices of Physicians (62111), Ambulatory Health Care Services (621)
- SIC
- Services-Medical Laboratories (8071), Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)
- akta.pro primary industry
- Inpatient Infectious Disease & Isolation Specialty Hospitals (HLAFAHAI)
- akta.pro secondary industries
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI), National Public Health Reference Laboratories (HLAJAIAA), Disease-Specific Reference Laboratory Networks (e.g., TB, HIV, Influenza) (HLAJAIAD), General Infectious Disease (HLAKAGAA), Public Health Laboratories & Diagnostic Oversight (BPAIAJAF), Laboratory Informatics & Reporting (LIMS/ELR) Public Health Networks (HLAJAIAN)
Keywords
Where IHU Méditerranée Infection is headquartered
LocationHeadquarters
- HQ city
- Marseille-en-beauvaisis
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
IHU Méditerranée Infection business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Others
Distribution channels3 records
Marketing channels6 records
IHU Méditerranée Infection product offering
Product offeringCore offering
IHU Méditerranée Infection is a French university hospital institute that delivers integrated infectious disease clinical care, advanced laboratory diagnostics, and scientific research from a single purpose-built facility in Marseille. The institute operates three National Reference Centers (Rickettsioses, ArboVIRUS, Malaria) and provides specialized reference diagnostic services to healthcare facilities across France. It also runs university education programs (Masters, Doctorate, Post-Doctorate), continuing education, and startup incubation services in the infectious disease domain.
Product overview
IHU Méditerranée Infection is a French university hospital institute (Institut Hospitalo-Universitaire) specializing in infectious and tropical diseases. Based in Marseille, it operates as an integrated research center combining clinical care, advanced laboratory diagnostics, and scientific research. The institute offers a comprehensive portfolio organized around four pillars: Soins (clinical care including hospitalization, consultations, vaccination, and day hospital services), Diagnostic (laboratory services including National Reference Centers for Rickettsioses, arboVIRUS, Malaria, and vector-borne diseases), Rechercher (research through units MEPHI, RITMES, SESSTIM, and UVE), and Innover (innovation platforms and incubation services). The institute maintains extensive technological platforms including next-generation sequencing (NGS), proteomics, culturomics, electron microscopy (scanning and transmission), biobanking, strain collections, serology, lyophilization, BSL3 laboratory, insectarium, and veterinary research center. Additionally, it provides public bioinformatics databases and tools including ARG-ANNOT, SVARAP/aSVARAP, Beta-lactamase Database, NRPPUR, Bacteriocins Database, URMS mass spectrometry reference, and Multi Spacers Typing (MST) for the scientific community.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Care Services (Soins)
Companies that use IHU Méditerranée Infection
Customer profileSegments5 records
Ideal customer profiles5 records
IHU Méditerranée Infection technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
IHU Méditerranée Infection partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, regional and minor.
- Aix-Marseille Université (AMU)corePrimary academic partner providing the university framework for research and education activities. The institute is integrated with AMU's Faculty of Medicine, enabling academic programs from Masters through Post-Doctorate levels.
- Assistance Publique - Hôpitaux de Marseille (AP-HM)coreParent public hospital system providing the clinical care infrastructure and patient access. AP-HM operates the hospital facilities within which the IHU delivers clinical services.
- CHU TimonecoreTeaching hospital within AP-HM serving as the primary clinical facility for the institute's infectious disease care and teaching activities.
- Infectiopole SudregionalSouthern France infectious disease network coordinating regional expertise in infectious diseases across the Provence-Alpes-Côte d'Azur and neighboring regions.
- HITACHI Educational ProgramminorEducational partnership program for specialized training in infectious diseases. The specific nature of the HITACHI partnership relates to educational content and training delivery.
Scale indicators7 records
Recent moves6 records
Expansion highlights5 records
IHU Méditerranée Infection competitors and assessment
Company assessmentOthers
- Assistance Publique – Hôpitaux de Marseille (AP-HM): Parent public hospital system hosting IHU's clinical activities and CHU Timone. Not a peer competitively but the structural host partner whose clinical infrastructure underwrites IHU's inpatient and ambulatory services.
Direct peers
- Swiss Tropical and Public Health Institute: Swiss institute associated with the University of Basel combining tropical medicine research, public health, and diagnostic reference work. Comparable scope in tropical/infectious disease research and international collaboration.
- Fondation Mérieux: French family foundation focused on fighting infectious diseases in developing countries through laboratory capacity building, diagnostics access, and applied research. Closely matches IHU's foundation structure and Global South orientation.
- Bernhard Nocht Institute for Tropical Medicine: Germany's reference center for tropical and infectious diseases, combining clinical care, reference diagnostics, and high-containment research. Mirrors IHU's integrated tropical medicine + reference laboratory + research model at European scale.
- Institut Pasteur: France's flagship private foundation for infectious disease research, clinical reference, and teaching. Comparable as a multi-center French infectious disease institute with CNR-equivalent functions, BSL infrastructure, and a global research footprint.
- Institut de Recherche pour le Développement (IRD): French public research organization with strong tropical and infectious disease programs across the Global South. Comparable partner profile, particularly given IHU's stated south-oriented international collaborations.
Broad incumbents
- London School of Hygiene & Tropical Medicine: Larger and longer-established European institution focused on infectious disease and public health research and education. Overlaps with IHU's research and teaching missions, particularly around tropical medicine and outbreak epidemiology.
- Wellcome Sanger Institute: Large UK genomics institute with major infectious disease surveillance and pathogen genomics programs (e.g., COVID-19 Genomics UK Consortium). Comparable on the genomics and bioinformatics database side of IHU's platform stack.
- National Institute of Allergy and Infectious Diseases (NIAID): US federal institute funding and conducting infectious and immune-mediated disease research globally. Much larger in scale but the closest analogue for an integrated research/reference/clinical infectious disease mission.
Emerging players
- Centre for Infectious Disease Research in Zambia (CIDRZ): African infectious disease research and implementation organization partnering with European reference institutes. Comparable as a Global South counterpart collaborating on tropical disease surveillance and laboratory capacity building.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
IHU Méditerranée Infection social profiles
Digital presenceIHU Méditerranée Infection financial estimates
Financial estimateRevenue estimate
Valuation estimate
IHU Méditerranée Infection leadership team
Management profileNumber of profiles
Profiles3 records
IHU Méditerranée Infection funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IHU Méditerranée Infection M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IHU Méditerranée Infection
What does IHU Méditerranée Infection do?
IHU Méditerranée Infection is a French university hospital institute that delivers integrated infectious disease clinical care, advanced laboratory diagnostics, and scientific research from a single purpose-built facility in Marseille. The institute operates three National Reference Centers (Rickettsioses, ArboVIRUS, Malaria) and provides specialized reference diagnostic services to healthcare facilities across France. It also runs university education programs (Masters, Doctorate, Post-Doctorate), continuing education, and startup incubation services in the infectious disease domain.
Is IHU Méditerranée Infection a public or private company?
IHU Méditerranée Infection is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was IHU Méditerranée Infection founded?
IHU Méditerranée Infection was founded in -1. It employs 101 to 250 people.
Where is IHU Méditerranée Infection based?
IHU Méditerranée Infection is headquartered in Marseille-en-beauvaisis, France, in the Europe region.
Who are IHU Méditerranée Infection's main competitors?
Assistance Publique – Hôpitaux de Marseille (AP-HM) is listed as an others. Direct peers are Swiss Tropical and Public Health Institute, Fondation Mérieux, Bernhard Nocht Institute for Tropical Medicine, Institut Pasteur and Institut de Recherche pour le Développement (IRD). Broad incumbents are London School of Hygiene & Tropical Medicine, Wellcome Sanger Institute and National Institute of Allergy and Infectious Diseases (NIAID). Centre for Infectious Disease Research in Zambia (CIDRZ) is listed as an emerging player.
Does IHU Méditerranée Infection have an API?
No public API is recorded for IHU Méditerranée Infection.
What industry is IHU Méditerranée Infection in?
IHU Méditerranée Infection's product category is Infectious Disease Research and Clinical Services. Its primary akta.pro industry code is HLAFAHAI, Inpatient Infectious Disease & Isolation Specialty Hospitals, with a secondary code of EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based). Its NAICS code is 621511 and its SIC code is 8071.